Recommendations for the reporting of pleural mesothelioma
- 1 November 2007
- journal article
- practice guideline
- Published by Elsevier in Human Pathology
- Vol. 38 (11) , 1587.e1-1587.e6
- https://doi.org/10.1016/j.humpath.2006.11.008
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesotheliomaLaboratory Investigation, 2005
- Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the PleuraLaboratory Investigation, 2000
- Important prognostic factors in patients with malignant pleural mesothelioma, managed surgicallyThe Annals of Thoracic Surgery, 1999
- Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Value of Cytokeratin 5/6 Immunostaining in Distinguishing Epithelial Mesothelioma of the Pleura From Lung AdenocarcinomaThe American Journal of Surgical Pathology, 1998
- TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lungCancer Letters, 1998
- Value of the Ber-EP4 Antibody in Differentiating Epithelial Pleural Mesothelioma From Adenocarcinoma:The M.D. Anderson Experience and a Critical Review of the LiteratureAmerican Journal of Clinical Pathology, 1998
- Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural MesotheliomaAnnals of Surgery, 1996
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995